The multidisciplinary, open-access journal PLOS ONE is seeking contributions to this collection. The accepted papers will form a PLOS ONE Collection/PLOS Medicine Special Issue, to be published in November 2019. Contributions should be submitted by 07 June 2019. You can find more information here: https://collections.plos.org/s/substance-use.
The Emory and Harvard Inter-CFAR Antiretrovirals for Prevention Working Group invite you to participate in our upcoming webinar, Monday, June 10, at 12:00 p.m. June’s webinar will feature Dr. Aaron Siegler. Dr. Siegler is an Associate Professor within the Department of Behavioral Sciences and Health Education at Emory University’s Rollins School of Public Health. His research explores the intersection of the biomedical and behavioral realms, with a focus on sexual minority populations and disparities in healthcare.
Dr. Siegler will be presenting on “Mobile Health Technology and Antiretrovirals for Prevention.” The presentation will focus on the direction of mobile health interventions, the best way to assess them and how to turn them into public health interventions.
Join Zoom Meeting: https://zoom.us/j/662559539
The objective of this FOA is to encourage research that addresses gaps in our knowledge of the oral health status of people living with HIV (PLWH), with an emphasis on PLWH who also have non-communicable diseases (NCDs). It supports efforts to understand the combined effects of HIV, antiretroviral therapy (ART), and NCDs on oral health, and it encourages identification of approaches for prevention and treatment of oral diseases and assessment of treatment outcomes in PLWH with or without NCDs. These efforts could help to generate evidence for oral health treatment guidelines tailored to the needs of dental patients with HIV.
LOI Due date: June 29th, 2019
See here for more details
NCI is hosting the 17th International Conference on Malignancies in HIV/AIDS on October 21-22, 2019 at the Lister Hill Center Auditorium on the campus of the National Institutes of Health in Bethesda, Maryland. Abstract Deadline is August 21, 2019. Click here for more details.
The NIAID New Innovator Award (DP2), PAR-19-296, was published last week. The purpose is to support post-doctoral investigators of exceptional creativity who propose highly innovative bold new research with the potential to produce a major impact on broad, important problems in biomedical research relevant to the mission of NIAID. Applicants approved for funding would have one year to secure an independent, tenure-track (or equivalent) faculty position at an U.S. extramural institution to activate the award.
The next receipt date is Oct 10, 2019 (once per year); clinical trials are not allowed for this FOA.